1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Macular Degeneration
1.2.3 Diabetic Macular Edema
1.2.4 Diabetic Retinopathy
1.2.5 Retinal Vein Occlusion
1.3 Market by Application
1.3.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disease Therapeutics Market Perspective (2017-2028)
2.2 Retinal Disease Therapeutics Growth Trends by Region
2.2.1 Retinal Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Retinal Disease Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Retinal Disease Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Retinal Disease Therapeutics Market Dynamics
2.3.1 Retinal Disease Therapeutics Industry Trends
2.3.2 Retinal Disease Therapeutics Market Drivers
2.3.3 Retinal Disease Therapeutics Market Challenges
2.3.4 Retinal Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disease Therapeutics Players by Revenue
3.1.1 Global Top Retinal Disease Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Disease Therapeutics Revenue
3.4 Global Retinal Disease Therapeutics Market Concentration Ratio
3.4.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Revenue in 2021
3.5 Retinal Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Retinal Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Retinal Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disease Therapeutics Breakdown Data by Type
4.1 Global Retinal Disease Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Retinal Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Retinal Disease Therapeutics Breakdown Data by Application
5.1 Global Retinal Disease Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Retinal Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Retinal Disease Therapeutics Market Size (2017-2028)
6.2 North America Retinal Disease Therapeutics Market Size by Type
6.2.1 North America Retinal Disease Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Retinal Disease Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Retinal Disease Therapeutics Market Share by Type (2017-2028)
6.3 North America Retinal Disease Therapeutics Market Size by Application
6.3.1 North America Retinal Disease Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Retinal Disease Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Retinal Disease Therapeutics Market Share by Application (2017-2028)
6.4 North America Retinal Disease Therapeutics Market Size by Country
6.4.1 North America Retinal Disease Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Retinal Disease Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Retinal Disease Therapeutics Market Size (2017-2028)
7.2 Europe Retinal Disease Therapeutics Market Size by Type
7.2.1 Europe Retinal Disease Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Retinal Disease Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Retinal Disease Therapeutics Market Share by Type (2017-2028)
7.3 Europe Retinal Disease Therapeutics Market Size by Application
7.3.1 Europe Retinal Disease Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Retinal Disease Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Retinal Disease Therapeutics Market Share by Application (2017-2028)
7.4 Europe Retinal Disease Therapeutics Market Size by Country
7.4.1 Europe Retinal Disease Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Retinal Disease Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Retinal Disease Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Retinal Disease Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Retinal Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinal Disease Therapeutics Market Size (2017-2028)
9.2 Latin America Retinal Disease Therapeutics Market Size by Type
9.2.1 Latin America Retinal Disease Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Retinal Disease Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Retinal Disease Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Retinal Disease Therapeutics Market Size by Application
9.3.1 Latin America Retinal Disease Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Retinal Disease Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Retinal Disease Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Retinal Disease Therapeutics Market Size by Country
9.4.1 Latin America Retinal Disease Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Retinal Disease Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disease Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Retinal Disease Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Retinal Disease Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Retinal Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Retinal Disease Therapeutics Introduction
11.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Retinal Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Retinal Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2017-2022)
11.3.5 Allergan Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Retinal Disease Therapeutics Introduction
11.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Regeneron
11.5.1 Regeneron Company Details
11.5.2 Regeneron Business Overview
11.5.3 Regeneron Retinal Disease Therapeutics Introduction
11.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2017-2022)
11.5.5 Regeneron Recent Developments
11.6 Santen
11.6.1 Santen Company Details
11.6.2 Santen Business Overview
11.6.3 Santen Retinal Disease Therapeutics Introduction
11.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2017-2022)
11.6.5 Santen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Retinal Disease Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Macular Edema
Table 4. Key Players of Diabetic Retinopathy
Table 5. Key Players of Retinal Vein Occlusion
Table 6. Global Retinal Disease Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Retinal Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Retinal Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Retinal Disease Therapeutics Market Share by Region (2017-2022)
Table 10. Global Retinal Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Retinal Disease Therapeutics Market Share by Region (2023-2028)
Table 12. Retinal Disease Therapeutics Market Trends
Table 13. Retinal Disease Therapeutics Market Drivers
Table 14. Retinal Disease Therapeutics Market Challenges
Table 15. Retinal Disease Therapeutics Market Restraints
Table 16. Global Retinal Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Retinal Disease Therapeutics Revenue Share by Players (2017-2022)
Table 18. Global Top Retinal Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disease Therapeutics as of 2021)
Table 19. Ranking of Global Top Retinal Disease Therapeutics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Retinal Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disease Therapeutics Product Solution and Service
Table 23. Date of Enter into Retinal Disease Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Retinal Disease Therapeutics Revenue Market Share by Type (2017-2022)
Table 27. Global Retinal Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Retinal Disease Therapeutics Revenue Market Share by Type (2023-2028)
Table 29. Global Retinal Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Retinal Disease Therapeutics Revenue Share by Application (2017-2022)
Table 31. Global Retinal Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Retinal Disease Therapeutics Revenue Share by Application (2023-2028)
Table 33. North America Retinal Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Retinal Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Retinal Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Retinal Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Retinal Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Retinal Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Retinal Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Retinal Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Retinal Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Retinal Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Retinal Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Retinal Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Retinal Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Retinal Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Retinal Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Retinal Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Retinal Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Retinal Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Retinal Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Retinal Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Retinal Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Retinal Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Retinal Disease Therapeutics Product
Table 66. Merck Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 67. Merck Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Retinal Disease Therapeutics Product
Table 71. Novartis Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Allergan Company Details
Table 74. Allergan Business Overview
Table 75. Allergan Retinal Disease Therapeutics Product
Table 76. Allergan Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 77. Allergan Recent Developments
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Retinal Disease Therapeutics Product
Table 81. Roche Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 82. Roche Recent Developments
Table 83. Regeneron Company Details
Table 84. Regeneron Business Overview
Table 85. Regeneron Retinal Disease Therapeutics Product
Table 86. Regeneron Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 87. Regeneron Recent Developments
Table 88. Santen Company Details
Table 89. Santen Business Overview
Table 90. Santen Retinal Disease Therapeutics Product
Table 91. Santen Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 92. Santen Recent Developments
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disease Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Macular Edema Features
Figure 4. Diabetic Retinopathy Features
Figure 5. Retinal Vein Occlusion Features
Figure 6. Global Retinal Disease Therapeutics Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Retinal Disease Therapeutics Report Years Considered
Figure 11. Global Retinal Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Retinal Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Retinal Disease Therapeutics Market Share by Region: 2021 VS 2028
Figure 14. Global Retinal Disease Therapeutics Market Share by Players in 2021
Figure 15. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disease Therapeutics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Retinal Disease Therapeutics Revenue in 2021
Figure 17. North America Retinal Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Retinal Disease Therapeutics Market Size Market Share by Type (2017-2028)
Figure 19. North America Retinal Disease Therapeutics Market Size Market Share by Application (2017-2028)
Figure 20. North America Retinal Disease Therapeutics Market Size Share by Country (2017-2028)
Figure 21. United States Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Retinal Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Retinal Disease Therapeutics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Retinal Disease Therapeutics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Retinal Disease Therapeutics Market Size Share by Country (2017-2028)
Figure 27. Germany Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Retinal Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Retinal Disease Therapeutics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Retinal Disease Therapeutics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Retinal Disease Therapeutics Market Size Share by Region (2017-2028)
Figure 37. China Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Retinal Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Retinal Disease Therapeutics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Retinal Disease Therapeutics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Retinal Disease Therapeutics Market Size Share by Country (2017-2028)
Figure 47. Mexico Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Retinal Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Retinal Disease Therapeutics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Retinal Disease Therapeutics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Retinal Disease Therapeutics Market Size Share by Country (2017-2028)
Figure 53. Turkey Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Merck Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
Figure 57. Novartis Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
Figure 58. Allergan Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
Figure 59. Roche Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
Figure 60. Regeneron Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
Figure 61. Santen Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
